250 related articles for article (PubMed ID: 19847569)
1. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.
Callender GG; Das P; Rodriguez-Bigas MA; Skibber JM; Crane CH; Krishnan S; Delclos ME; Feig BW
Ann Surg Oncol; 2010 Feb; 17(2):441-7. PubMed ID: 19847569
[TBL] [Abstract][Full Text] [Related]
2. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
3. Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis.
Shin YS; Yu CS; Park JH; Kim JC; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Joo JH; Kim JH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):136-144. PubMed ID: 28816139
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
[TBL] [Abstract][Full Text] [Related]
6. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
7. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
[TBL] [Abstract][Full Text] [Related]
8. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis.
Shin YS; Park JH; Yoon SM; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Choi EK; Ahn SD; Lee SW; Kim JH
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):630-639. PubMed ID: 29678529
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
11. Local excision of T1 and T2 rectal cancer: proceed with caution.
Elmessiry MM; Van Koughnett JA; Maya A; DaSilva G; Wexner SD; Bejarano P; Berho M
Colorectal Dis; 2014 Sep; 16(9):703-9. PubMed ID: 24787457
[TBL] [Abstract][Full Text] [Related]
12. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
13. Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified.
Yang KM; Lim SB; Lee JL; Kim CW; Yoon YS; Park IJ; Yu CS; Kim JC
Int J Colorectal Dis; 2018 Apr; 33(4):487-491. PubMed ID: 29468352
[TBL] [Abstract][Full Text] [Related]
14. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.
Belluco C; De Paoli A; Canzonieri V; Sigon R; Fornasarig M; Buonadonna A; Boz G; Innocente R; Perin T; Cossaro M; Polesel J; De Marchi F
Ann Surg Oncol; 2011 Dec; 18(13):3686-93. PubMed ID: 21691880
[TBL] [Abstract][Full Text] [Related]
16. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
[TBL] [Abstract][Full Text] [Related]
17. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
18. Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial.
Wang F; Fan W; Peng J; Lu Z; Pan Z; Li L; Gao Y; Li H; Chen G; Wu X; Ding P; Zeng Z; Wan D
Cancer Commun (Lond); 2018 Dec; 38(1):73. PubMed ID: 30572939
[TBL] [Abstract][Full Text] [Related]
19. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers.
Mohiuddin M; Marks G; Bannon J
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):845-9. PubMed ID: 7960986
[TBL] [Abstract][Full Text] [Related]
20. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
